Thursday, July 26, 2007 - (Byron J. Richards, CCN)
Question: What does the FDA do when a new potential blockbuster drug poses a significant risk for heart failure?
Answer: It removes the lead scientist from the drug’s approval process to silence the problem.
Monday, July 02, 2007 - (Byron J. Richards, CCN)
Fake drug safety legislation now moves to the floor of the House (H.R. 2900). The Senate has already passed its similar version (S.1082). Within this legislation is a blatant attack by the FDA on dietary supplements. The FDA is seeking the power to brand dietary supplements as unsafe using drug related risk-benefit analysis. Unless the wording in the bill is changed the FDA will have the power to remove any dietary supplement from the market based on its opinion. The bill is expected to come to the floor of the House for debate and vote during the second or third week of July.
